tiprankstipranks
Acura Pharmaceuticals, Inc. (ACUR)
:ACUR
US Market

Acura Pharmaceuticals (ACUR) Income Statement

Compare
80 Followers

Acura Pharmaceuticals Income Statement

Last quarter (Q3 2023), Acura Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Acura Pharmaceuticals's net income was $0.00. See Acura Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 1.56M$ 3.57M$ 2.66M$ 410.00K
Gross Profit
$ 0.00$ 352.00K$ 3.57M$ 2.66M$ 408.24K
Operating Expenses
$ 0.00$ 2.78M$ 4.33M$ 3.38M$ 4.33M
Depreciation and Amortization
$ 228.49K$ 90.00K$ 125.00K$ 273.00K$ 280.00K
EBITDA
$ 0.00$ -589.00K$ -633.00K$ -3.04M$ -3.17M
Operating Income
$ 0.00$ -1.21M$ -758.00K$ -725.00K$ -3.92M
Other Income/Expenses
$ 0.00$ 335.00K$ -450.00K$ -3.05M$ 73.00K
Pretax Income
$ 0.00$ -879.00K$ -1.21M$ -3.77M$ -3.84M
Net Income
$ 0.00$ -1.08M$ -1.66M$ -3.95M$ -3.84M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -0.02$ -0.05$ -0.15$ -0.18
Diluted EPS
$ 0.00$ -0.02$ -0.05$ -0.15$ -0.18
Weighted Average Shares Outstanding
0.00 56.80M 32.32M 26.72M 21.15M
Weighted Average Shares Outstanding (Diluted)
0.00 56.80M 32.32M 26.72M 21.15M
Currency in USD

Acura Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis